Pharmacie sans ordonnance livraison rapide 24h: acheter viagra en ligne en France.
GHS SAFETY DATA SHEET
Date Revised: JAN 2013
SCIGRIP® 10 Low VOC 2-Component Adhesive
SECTION I - PRODUCT AND COMPANY IDENTIFICATION
SCIGRIP® 10 Low VOC 2-Component Adhesive (Refer to Technical Data Sheet for Mix ratio)
2-Component Cartridge, high-strength, high viscosity, reactive Structural Adhesive
SCIGRIP Smarter Adhesive Solutions
600 Ellis Road, Durham,NC 27703 - USA
P.O. Box 12729, Research Triangle Park, NC 27709 - USA
Transportation: CHEMTEL Tel. 800.255-3924, 813-248-0585 (International)
Tel. 800.451.8346, 760.602.8703 3E Company (International)
SECTION 2 - HAZARDS IDENTIFICATION
P262: Do not get in eyes, on skin, or on clothing
P271 - Use only outdoors or in a well-ventilated area
H317 - May cause an allergic skin reaction
EUH066 - Repeated exposure may cause skin dryness or cracking
SECTION 3 - COMPOSITION/INFORMATION ON INGREDIENTS
Component "A" (Base Resin)
% by Weight
Methyl Methacrylate Monomer (MMA),* Stabilized
Component "B" (Catalyst-Initiator)
Methyl Ethyl Ketone (MEK)
All of the constituents of this adhesive product are listed on the TSCA inventory of chemical substances maintained by the US EPA, or are exempt from that listing. *Indicates this chemical is subject to the reporting requirements of Section 313 of the Emergency Planning and Community Right-to-Know Act of 1986 (40CFR372).
# indicates that this chemical is found on Proposition 65’s List of chemicals known to the State of California to cause cancer or reproductive toxicity.
SECTION 4 - FIRST AID MEASURES
Contact with eyes:
Flush eyes immediately with plenty of water for 15 minutes and seek medical advice immediately.
Remove contaminated clothing and shoes. Wash skin thoroughly with soap and water. If irritation develops, seek medical advice.
Remove to fresh air. If breathing is stopped, give artificial respiration. If breathing is difficult, give oxygen. Seek medical advice.
Rinse mouth with water. Give 1 or 2 glasses of water or milk to dilute. Do not induce vomiting. Seek medical advice immediately.
SECTION 5 - FIREFIGHTING MEASURES
Suitable Extinguishing Media:
Dry chemical powder, carbon dioxide gas, foam, Halon, water fog.
Unsuitable Extinguishing Media:
Oxides of carbon, oxides of nitrogen, hydrogen chloride
hydrocarbons, acrid smoke and toxic gases.
Protection for Firefighters:
Self-contained breathing apparatus or full-face positive pressure air-supply masks.
SECTION 6 - ACCIDENTAL RELEASE MEASURES
Keep away from heat, sparks and open flame.
Provide sufficient ventilation, use explosion-proof exhaust ventilation equipment or wear suitable respiratory protective equipment.
Prevent contact with skin or eyes (see section 8).
Prevent product or liquids contaminated with product from entering sewers, drains, soil or open water course.
Methods for Cleaning up:
Contain spill with sand or other inert adsorbent or absorbent material. Use non-sparking tools. Transfer to a closable vessel (Metal or polyethylene [PE])
SECTION 7 - HANDLING AND STORAGE
Avoid breathing of vapor, avoid contact with eyes, skin and clothing.
Keep away from ignition sources, use only electrically grounded handling equipment and ensure adequate ventilation/fume exhaust hoods.
Do not eat, drink or smoke while handling.
Store between 50° - 80°F (10° - 27°C). Store in ventliated room or shade and away from direct sunlight. Keep container tightly closed when not in use.
Keep away from ignition sources and incompatible materials. Follow all precautionary information on container label and product bulletins.
SECTION 8 - PRECAUTIONS TO CONTROL EXPOSURE / PERSONAL PROTECTION
ACGIH STEL OSHA PEL
Maintain breathing zone airborne concentrations below exposure limits.
Personal Protective Equipment (PPE):
Avoid contact with eyes, wear splashproof chemical goggles, face shield, safety glasses (spectacles) with brow guards and side shields,
Prevent contact with the skin as much as possible. Butyl rubber gloves should be used for frequent immersion. Use of solvent-resistant gloves or solvent-resistant barrier cream should provide adequate protection when normal adhesive applicationpractices and procedures are used for making structural bonds.
Use in a well-ventilated room. Use local exhaust ventilation to remove airborne contaminants from employee breathing zone
and to keep contaminants below levels listed above. With normal use, the Exposure Limit Value will not usually be reached. When limits approached, use respiratory protection equipment.
FileName: SG10_Cart_LoVOC_012113.xls Page 1 of 2
GHS SAFETY DATA SHEET
Date Revised: JAN 2013
SCIGRIP® 10 Low VOC 2-Component Adhesive
SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES
"A" White, viscous liquid; "B" Clear, syrupy liquid
"A" Acrid odor, "B" Ketone
Active Oxygen Content:
"A" 100.5°C (212.9°F) Based on first boiling component: MMA
"A" > 1.0 (BUAC = 1), "B" <1
"A" Category 2, "B" Category 2
"A" 11.5°C (52.7°F) T.C.C. based on MMA, "B" -9°C (15.8°F) for MEKFlammability Limits:
"A" 1.6 (MMA), "B" - 1.4(MEK)
"A" 1.053 @23°C (73°F), "B" 0.950 @23°C (73°F)
"A" 12.5(MMA), "B" 11.4(MEK)
"A" Slight in Water (MMA); "B" 27.5%/MEK @ 20°C (68°F)
"A" 421°C (789.8°F): MMA, "B" 404°C (759°F): MEK
"A" 29 mm Hg @ 20°C (68°F): MMA
"A" < 50 g/l mixed, "B" N/E
"A" > 3 Air = 1), "B" - N/E
SECTION 10 - STABILITY AND REACTIVITY
Hazardous decomposition products:
None in normal use. Oxides of carbon, oxides of nitrogen, hydrogen chloride, hydrocarbons, acrid smoke and toxic gases upon combustion.
Conditions to avoid:
Keep away from direct sunlight, heat, temperatures above 29°C (85°F), sparks, open flame and other ignition sources.
Reducing and oxidizing agents and metal contaminants
SECTION 11 - TOXICOLOGICAL INFORMATION
Likely Routes of Exposure:
Acute symptoms and effects:
Severe overexposure may result in nausea, dizziness, headache. Can cause drowsiness, irritation of eyes and nasal passages.
Vapors slightly uncomfortable. Overexposure may result in severe eye injury with corneal or conjunctival inflammation on contact with the liquid.
Liquid contact may remove natural skin oils resulting in skin irritation. Dermatitis may occur with prolonged contact.
May cause nausea, vomiting, diarrhea and mental sluggishness.
Chronic (long-term) effects:
Oral: 7900 mg/kg (rat), Dermal: >35000 mg/kg (rabbit) I
Oral: 2737 mg/kg (rat), Dermal: 6480 mg/kg (rabbit)
Oral: 1600 mg/kg (rat), Dermal: 500 mg/kg (rabbit)
Sensitization to Product
SECTION 12 - ECOLOGICAL INFORMATION
In normal use, emission of volatile organic compounds (VOC's) to the air takes place, typically at a rate of < 50 g/l
SECTION 13 - WASTE DISPOSAL CONSIDERATIONS
Follow local and national regulations. Consult local disposal expert.
SECTION 14 - TRANSPORT INFORMATION
Proper Shipping Name:
EXCEPTION for Ground Shipping
DOT Limited Quantity:
Up to 5L per inner packaging, 30 kg gross weight per package.
Depending on packaging, these quantities may qualify under DOT as "ORM-D" .
SECTION 15 - REGULATORY INFORMATION
Precautionary Label Information:
Ingredient Listings: USA TSCA, Europe EINECS, Canada DSL, Australia
R66 - Repeated exposure may cause skin dryness or cracking
R-36/37/38 Irritating to eyes, respiratory system and skin
R67 - Vapors may cause drowsiness and dizziness
R-43 May cause sensitization by skin contact.
S-26 In case of contact with eyes, rinse immediately with plenty of water and seek medical advice
S-36/37/39 Wear suitable protective clothing, gloves and eye/face protection
S-46 If swallowed, seek medical advise immediately and show this container or label
S-24/25 Avoid contact with skin and eyes.
SECTION 16 - OTHER INFORMATION
Department issuing data sheet:
IPS, Safety Health & Environmental Affairs
All ingredients are compliant with the requirements of the European
Directive on RoHS (Restriction of Hazardous Substances).
Yes, training in practices and procedures contained in product literature.
Reissue date / reason for reissue:
Intended Use of Product:
Reactive acrylic adhesive bonding/cementing plastics and other substrates
Not recommended for use on PTFE, Silicone, Polypropylene, Polyethylene and other Polyolefin's or joints with an interference fit.
This product is intended for use by skilled individuals at their own risk. The information contained herein is based on data considered accurate based on current state ofknowledge and experience. However, no warranty is expressed or implied regarding the accuracy of this data or the results to be obtained from the use thereof.
FileName: SG10_Cart_LoVOC_012113.xls Page 2 of 2
A R R E T E N°2010-09858 Accordant la médaille d'honneur régionale, départementale A l'occasion de la promotion du 1er janvier 2011; VU le décret n° 87-594 du 22 juillet 1987, portant création de la Médaille d'Honneur Régionale, Départementale et Communale, VU le décret n°88-309 du 28 mars 1988, VU le décret n°2005-48 du 25 janvier 2005. Article 1. - La médaille d’ho
Dr. W ilhelm Lehmann, DUR Board Chairman Editors: Tim Morley, R.Ph. , Lisa Hulbert, R.Ph. Jennifer Zeleny, CphT. , MPH., Duane Parke, R.Ph. An “unofficial” publication of the State Medicaid DUR Board Preferred Drug List Update Prior Authorization Changes During the 2009 legislative session, the State Legislature approved SB87, which authorizes Utah Medicaid to require a Prio